Cancer was responsible for around 142 deaths per 100,000 population in the United States in 2022. The death rate for cancer has steadily decreased since the 1990’s, but cancer still remains the second leading cause of death in the United States. The deadliest type of cancer for both men and women is cancer of the lung and bronchus which will account for an estimated 65,790 deaths among men alone in 2024. Probability of surviving Survival rates for cancer vary significantly depending on the type of cancer. The cancers with the highest rates of survival include cancers of the thyroid, prostate, and testis, with five-year survival rates as high as 99 percent for thyroid cancer. The cancers with the lowest five-year survival rates include cancers of the pancreas, liver, and esophagus. Risk factors It is difficult to determine why one person develops cancer while another does not, but certain risk factors have been shown to increase a person’s chance of developing cancer. For example, cigarette smoking has been proven to increase the risk of developing various cancers. In fact, around 81 percent of cancers of the lung, bronchus and trachea among adults aged 30 years and older can be attributed to cigarette smoking. A recent poll indicated that many U.S. adults believed smoking cigarettes and using other tobacco products increased a person’s risk of developing cancer, but a much smaller percentage believed the same for proven risk factors such as obesity and drinking alcohol.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
TD: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 23.400 % in 2021. This records a decrease from the previous number of 24.500 % for 2020. TD: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 25.250 % from Dec 2000 (Median) to 2021, with 22 observations. The data reached an all-time high of 25.800 % in 2003 and a record low of 23.400 % in 2021. TD: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Chad – Table TD.World Bank.WDI: Social: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.4.1 [https://unstats.un.org/sdgs/metadata/].
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Directly standardised mortality rate from cancer for people aged under 75, per 100,000 population. To ensure that the NHS is held to account for doing all that it can to prevent deaths from cancer in people under 75. Legacy unique identifier: P01733
In the United States in 2021, the death rate was highest among those aged 85 and over, with about 17,190.5 men and 14,914.5 women per 100,000 of the population passing away. For all ages, the death rate was at 1,118.2 per 100,000 of the population for males, and 970.8 per 100,000 of the population for women. The death rate Death rates generally are counted as the number of deaths per 1,000 or 100,000 of the population and include both deaths of natural and unnatural causes. The death rate in the United States had pretty much held steady since 1990 until it started to increase over the last decade, with the highest death rates recorded in recent years. While the birth rate in the United States has been decreasing, it is still currently higher than the death rate. Causes of death There are a myriad number of causes of death in the United States, but the most recent data shows the top three leading causes of death to be heart disease, cancers, and accidents. Heart disease was also the leading cause of death worldwide.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Directly age standardised mortality rate from breast cancer for females in the respective time period per 100,000 registered female patients. March 2020: In addition to the changes in March 2019, the indicator production process has been fully automated. As a result there are two changes to this publication: 1) Data in this file are published for 2016-2018 only; all data is based on the most recent methodology. For the historic time series of this indicator please refer to the zip files in the June 2018 publication: https://digital.nhs.uk/data-and-information/publications/clinical-indicators/ccg-outcomes-indicator-set/archive/ccg-outcomes-indicator-set---june-2018 Please note, neither version of the file contains data for 2015-2017; changes in the data processing meant the 2015 data was not comparable to the 2016 and 2017 data processed under the new method. 2) Data are run against CCGs which were in existence at the time of processing. As of the March 2019 release the processing of the Primary Care Mortality Database (PCMD) and the standard population used to calculate the indicator for new data periods changed; this file now contains only those data periods processed under the new method. For the historic time series of this indicator please refer to the June 2018 publication referenced above. Legacy unique identifier: P01819
According to the data, the number of individuals who died from a tumor in Italy decreased constantly between 2006 and 2021. Indeed, the rate of deaths due to cancer among Italians dropped from 28.7 deaths per 10,000 inhabitants in 2006 to 23.3 in 2021. Moreover, in Italy, the cancer mortality rates among women and men are lower than the ones observed in the European Union. Women’s cancer Breast cancer is the most common and deadliest type of cancer among women in Italy. As a matter of fact, around 834 thousand women in Italy were living with a diagnosis of breast cancer in 2023, and over 15.4 thousand died from it in 2022. Colorectal and lung cancer follow in the list of the most frequently diagnosed cancers among females in Italy. Men’s cancer The most frequently diagnosed cancer among males in Italy is prostate cancer. Lung cancer, which is also the deadliest type of cancer for men, follows. As of 2023, the number of men living with a diagnosis of prostate cancer in Italy amounted to 564 thousand, while the number of new cases of prostate cancer during that year was estimated at 41.1 thousand.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Azerbaijan Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 17.400 % in 2021. This records a decrease from the previous number of 21.600 % for 2020. Azerbaijan Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 26.850 % from Dec 2000 (Median) to 2021, with 22 observations. The data reached an all-time high of 34.500 % in 2000 and a record low of 17.400 % in 2021. Azerbaijan Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Azerbaijan – Table AZ.World Bank.WDI: Social: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.4.1 [https://unstats.un.org/sdgs/metadata/].
Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.
Abstract Background: This study analyzed the causes of death in the Korean population in 2020. Methods: Cause-of-death data for 2020 from Statistics Korea were examined based on the Korean Standard Classification of Diseases and Causes of Death, 7th revision and the International Statistical Classification of Diseases and Related Health Problems, 10th revision. Results: In total, 304,948 deaths occurred, reflecting an increase of 9,838 (3.3%) from 2019. The crude death rate (the number of deaths per 100,000 people) was 593.9, corresponding to an increase of 19.0 (3.3%) from 2019. The 10 leading causes of death, in descending order, were malignant neoplasms, heart diseases, pneumonia, cerebrovascular diseases, intentional self-harm, diabetes mellitus, Alzheimer’s disease, liver diseases, hypertensive diseases, and sepsis. Cancer accounted for 27.0% of deaths. Within the category of malignant neoplasms, the top 5 leading organs of involvement were the lung, liver, colon, stomach, and pancreas. Sepsis was included in the 10 leading causes of death for the first time. Mortality due to pneumonia decreased to 43.3 (per 100,000 people) from 45.1 in 2019. The number of deaths due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was 950, of which 54.5% were in people aged 80 or older. Conclusion: These changes reflect the continuing increase in deaths due to diseases of old age, including sepsis. The decrease in deaths due to pneumonia may have been due to protective measures against SARS-CoV-2. With the concomitant decrease in fertility, 2020 became the first year in which Korea’s natural total population decreased.
According to the latest reports, more people died in Spain than were being born, with figures reaching over 439,000 deaths versus 322,000 newborns. The number of deaths experienced an upward trend over the 11-year period, presumably due to Spain’s aging population and in more recent years, the spread of COVID-19. Circulatory system diseases and cancer ranked as the most common causes of death in SpainThe cause of death can vary significantly across the globe and depends highly on economic development, presence of a competent healthcare system and one’s choices in lifestyle. In Spain, diseases related to the circulatory system and certain infectious and parasitic diseases ranked as the main causes of death, amounting to nearly 50,000 cases in the 2022. The annual number of deaths as a result of a disease of the circulatory system maintained steadily over the most recent years, with the illness being more common among female than male individuals. Cancer numbers in SpainThe number of deaths as a result of a cancer grew steadily in Spain for both women and men, although the disease seems to affect more male individuals than female, with about 68,000 cases occurring in men and 45,000 in women according to the most recent data. Furthermore, of the total 276,260 new cases of cancer in Spain in 2023, roughly 158,500 were diagnosed among male individuals.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Canada CA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 9.700 % in 2021. This records a decrease from the previous number of 10.000 % for 2020. Canada CA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 11.000 % from Dec 2000 (Median) to 2021, with 22 observations. The data reached an all-time high of 14.400 % in 2000 and a record low of 9.600 % in 2019. Canada CA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Canada – Table CA.World Bank.WDI: Social: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.4.1 [https://unstats.un.org/sdgs/metadata/].
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Austria AT: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 9.900 % in 2021. This records a decrease from the previous number of 10.100 % for 2020. Austria AT: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 12.150 % from Dec 2000 (Median) to 2021, with 22 observations. The data reached an all-time high of 15.300 % in 2000 and a record low of 9.900 % in 2021. Austria AT: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Austria – Table AT.World Bank.WDI: Social: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.4.1 [https://unstats.un.org/sdgs/metadata/].
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Belgium BE: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 9.200 % in 2021. This records an increase from the previous number of 9.100 % for 2020. Belgium BE: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 12.750 % from Dec 2000 (Median) to 2021, with 22 observations. The data reached an all-time high of 15.400 % in 2000 and a record low of 9.100 % in 2020. Belgium BE: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Belgium – Table BE.World Bank.WDI: Social: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.4.1 [https://unstats.un.org/sdgs/metadata/].
This multi-scale map shows life expectancy - a widely-used measure of health and mortality. From the 2020 County Health Rankings page about Life Expectancy:"Life Expectancy is an AverageLife Expectancy measures the average number of years from birth a person can expect to live, according to the current mortality experience (age-specific death rates) of the population. Life Expectancy takes into account the number of deaths in a given time period and the average number of people at risk of dying during that period, allowing us to compare data across counties with different population sizes.Life Expectancy is Age-AdjustedAge is a non-modifiable risk factor, and as age increases, poor health outcomes are more likely. Life Expectancy is age-adjusted in order to fairly compare counties with differing age structures.What Deaths Count Toward Life Expectancy?Deaths are counted in the county where the individual lived. So, even if an individual dies in a car crash on the other side of the state, that death is attributed to his/her home county.Some Data are SuppressedA missing value is reported for counties with fewer than 5,000 population-years-at-risk in the time frame.Measure LimitationsLife Expectancy includes mortality of all age groups in a population instead of focusing just on premature deaths and thus can be dominated by deaths of the elderly.[1] This could draw attention to areas with higher mortality rates among the oldest segment of the population, where there may be little that can be done to change chronic health problems that have developed over many years. However, this captures the burden of chronic disease in a population better than premature death measures.[2]Furthermore, the calculation of life expectancy is complex and not easy to communicate. Methodologically, it can produce misleading results caused by hidden differences in age structure, is sensitive to infant and child mortality, and tends to be overestimated in small populations."Click on the map to see a breakdown by race/ethnicity in the pop-up: Full details about this measureThere are many factors that play into life expectancy: rates of noncommunicable diseases such as cancer, diabetes, and obesity, prevalence of tobacco use, prevalence of domestic violence, and many more.Data from County Health Rankings 2020 (in this layer and referenced below), available for nation, state, and county, and available in ArcGIS Living Atlas of the World
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Excess Under 75 Mortality Rates in Adults With Serious Mental Illness, Excess under 75 mortality rates in adults with serious mental illness - 2020 to 2022 This indicator is a measure of the extent to which adults with a serious mental illness (SMI) die younger than adults without a serious mental illness (nSMI). The data files for the previous publications have been revised and updated inline with the processing used for this publication (2020-2022) and to reflect the revised population estimates for 2012 through to 2020 following the 2021 Census. To measure premature mortality in adults diagnosed with a serious mental illness (SMI).
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Argentina AR: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 13.400 % in 2021. This records a decrease from the previous number of 14.700 % for 2020. Argentina AR: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 17.200 % from Dec 2000 (Median) to 2021, with 22 observations. The data reached an all-time high of 20.000 % in 2000 and a record low of 13.400 % in 2021. Argentina AR: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Argentina – Table AR.World Bank.WDI: Social: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.4.1 [https://unstats.un.org/sdgs/metadata/].
According to preliminary data between January and October 2024, ** percent of deaths were caused by neoplasms or cancer diseases in the Philippines. Deaths from such illness were lowest in 2021 across the country, amounting to *** percent.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Armenia AM: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 20.600 % in 2021. This records a decrease from the previous number of 21.300 % for 2020. Armenia AM: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 24.250 % from Dec 2000 (Median) to 2021, with 22 observations. The data reached an all-time high of 27.500 % in 2000 and a record low of 20.100 % in 2018. Armenia AM: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Armenia – Table AM.World Bank.WDI: Social: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.4.1 [https://unstats.un.org/sdgs/metadata/].
https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
According to cognitive market research, the Global radiofrequency ablation devices market was valued at USD xx million in 2024, growing at a CAGR of xx% during the forecast period from 2024 to 2030 to reach USD xx billion by 2031.
The demand for radiofrequency ablation devices is witnessing growth due to the growing prevalence of chronic diseases such as cardiovascular diseases, cancers, rising geriatric population, and technological advancement in product development and design improvement. Radiofrequency ablation device that uses radio waves to heat and destroy abnormal cells.
The rise in the no of geriatric population is expected to raise the market growth of the radiofrequency ablation device market for pain management over the forecast period. The elderly population often experiences a higher incidence of chronic conditions such as cancer, cardiac arrhythmias, and musculoskeletal disorders which may require treatment with RFA.
Innovations in energy delivery systems, imaging guidance techniques and temperature monitoring technologies can enhance treatment outcomes and patient experience. With a growing trend towards minimally invasive procedures, there is an opportunity for RFA devices to gain market share as patients and healthcare providers seek alternatives to traditional surgical interventions.
Compared to traditional surgical interventions, RFA offers several advantages, including shorter recovery times, reduced risk of complications, and the ability to treat tumors in difficult-to-reach locations. As patients and healthcare providers increasingly prioritize minimally invasive treatment options, the demand for RFA devices is expected to rise.
Radiofrequency ablation is an effective treatment for small cancers. Furthermore, radiofrequency ablation is not the main treatment for cancers, it is often used as an alternative treatment, therefore the rising prevalence of cancers of different etiologies is also expected to contribute to the growing demand for radiofrequency ablation devices during the forecast period.
Market Dynamics of the Radiofrequency Ablation Devices Market
Key Drivers of the Radiofrequency Ablation Devices Market
A rise in cancer incidences is expected to propel the growth of global radiofrequency ablation device market
Cancer incidence rates have been steadily increasing globally due to factors such as the aging population, lifestyle changes, environmental factors, and improved detection and diagnosis. As the no of cancer cases rises, there is a corresponding increase in the demand for effective treatment modalities, including radiofrequency ablation. Radiofrequency ablation is a minimally invasive procedure that utilizes heat generated from radiofrequency waves to destroy cancerous cells. Compared to traditional surgical interventions, RFA offers several advantages, including shorter recovery times, reduced risk of complications, and the ability to treat tumors in difficult-to-reach locations. As patients and healthcare providers increasingly prioritize minimally invasive treatment options, the demand for RFA devices is expected to rise. The most common cancers are breast cancer, lung cancer, and colon and rectum cancer. Breast cancer was the most common disease in 2020. • For instance, in February 2022, according to data provided by the World Health Organization cancer was a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths due to cancer. (Source:https://www.who.int/news-room/fact-sheets/detail/cancer)
An increase in the no of geriatric people who receive treatment from radiofrequency ablation devices propels the market growth.
The rise in the no of geriatric population is expected to raise the market growth of the radiofrequency ablation device market for pain management over the forecast period. The elderly population often experiences a higher incidence of chronic conditions such as cancer, cardiac arrhythmias, and musculoskeletal disorders which may require treatment with RFA. As the geriatric population grows so does the demand for minimally invasive treatment options like RFA to manage these conditions effectively. Aging is associated with an increased risk of certain diseases and conditions, including various types of cancer, and osteoid osteomas. RFA offers a minimally invasive approach to treating these conditions, making it an attractive optio...
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Comoros KM: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 20.200 % in 2021. This records a decrease from the previous number of 21.000 % for 2020. Comoros KM: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 21.300 % from Dec 2000 (Median) to 2021, with 22 observations. The data reached an all-time high of 26.300 % in 2000 and a record low of 20.200 % in 2021. Comoros KM: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Comoros – Table KM.World Bank.WDI: Social: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.4.1 [https://unstats.un.org/sdgs/metadata/].
Cancer was responsible for around 142 deaths per 100,000 population in the United States in 2022. The death rate for cancer has steadily decreased since the 1990’s, but cancer still remains the second leading cause of death in the United States. The deadliest type of cancer for both men and women is cancer of the lung and bronchus which will account for an estimated 65,790 deaths among men alone in 2024. Probability of surviving Survival rates for cancer vary significantly depending on the type of cancer. The cancers with the highest rates of survival include cancers of the thyroid, prostate, and testis, with five-year survival rates as high as 99 percent for thyroid cancer. The cancers with the lowest five-year survival rates include cancers of the pancreas, liver, and esophagus. Risk factors It is difficult to determine why one person develops cancer while another does not, but certain risk factors have been shown to increase a person’s chance of developing cancer. For example, cigarette smoking has been proven to increase the risk of developing various cancers. In fact, around 81 percent of cancers of the lung, bronchus and trachea among adults aged 30 years and older can be attributed to cigarette smoking. A recent poll indicated that many U.S. adults believed smoking cigarettes and using other tobacco products increased a person’s risk of developing cancer, but a much smaller percentage believed the same for proven risk factors such as obesity and drinking alcohol.